Charles River Laboratories International Inc. has signed a definitive agreement to acquire Vigene Biosciences Inc., a premier, U.S.-based gene therapy contract development and manufacturing organization (CDMO) providing viral vector-based gene ...
Vigene Biosciences, a global gene therapy development company, has unveiled plans to expand into a new facility in Montgomery County in Maryland to accommodate industry demand for its gene and cellular therapy products.